Kavita V Nair
Affiliation: University of Colorado Denver
- Work absences and expenditures for employees with autoimmune inflammatory diseasesKavita V Nair
School of Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
J Occup Environ Med 54:1268-74. 2012..Economic burden was compared for employees with autoimmune inflammatory diseases (AutoIDs) who received anti-tumor necrosis factor (TNF) α agents, those who did not, and those with no AutoID...
- Burden of illness for an employed population with chronic obstructive pulmonary diseaseKavita Nair
School of Pharmacy, University of Colorado Denver, Denver, CO 80045, USA
Popul Health Manag 15:267-75. 2012..By understanding these costs, employers may evaluate disease management programs and treatment to improve outcomes for employees with COPD. Improved treatment options may reduce the direct and indirect costs of COPD...
- Comparing pre-gap and gap behaviors for Medicare beneficiaries in a Medicare managed care planKavita V Nair
School of Pharmacy, University of Colorado, Aurora, Colorado, USA
J Health Care Finance 38:38-53. 2011..To examine the impact of the coverage gap on pharmacy use, expenditures, and out-of-pocket costs for Medicare managed care beneficiaries before and after reaching the gap...
- Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetesR Brett McQueen
Pharmaceutical Outcomes Research Program, School of Pharmacy, University of Colorado Denver, Aurora, Colorado, USA
Cost Eff Resour Alloc 9:13. 2011..abstract:..
- Use of diagnostic tests and procedures for disease-modifying therapy users and non-disease-modifying therapy users with multiple sclerosisKavita V Nair
School of Pharmacy, C238 L15, University of Colorado Denver, Academic Office 1, 12631 E 17th Avenue, Room L15 1406, PO Box 6511, Aurora, CO 80045, USA
Expert Rev Neurother 11:787-98. 2011..7%) and liver function tests (60.5%). Relative to non-DMT users (n = 25,534), DMT users were more likely to receive an MRI, neuropsychological testing, chemistry panels, complete blood cell counts and liver function tests...
- Consumer-driven health plans: impact on utilization and expenditures for chronic disease sufferersKavita V Nair
School of Pharmacy, University of Colorado at Denver, Aurora, Colo 80045, USA
J Occup Environ Med 51:594-603. 2009..The impact of consumer-driven health plans (CDHPs) on utilization and expenditures for members with chronic diseases...
- Prescription co-pay reduction program for diabetic employeesKavita V Nair
School of Pharmacy, University of Colorado Denver, Denver, CO 80045, USA
Popul Health Manag 13:235-45. 2010..In addition to financial strategies, additional strategies to reinforce medication adherence are needed to gain and sustain more meaningful increases in prescription utilization...
- A retrospective cohort study of correlates of response to pharmacologic therapy for hyperlipidemia in members of a managed care organizationRobert J Valuck
University of Colorado Health Sciences Center, School of Pharmacy, Denver, Colorado 80262, USA
Clin Ther 25:2936-57. 2003..Few studies have examined the effectiveness of statins in a managed care setting...
- Effects of a 3-tier pharmacy benefit design on the prescription purchasing behavior of individuals with chronic diseaseKavita V Nair
University of Colorado Health Sciences Center, School of Pharmacy, 4200 East Ninth Ave, Box C 238, Denver, CO 80262, USA
J Manag Care Pharm 9:123-33. 2003..To evaluate the impact of 3-tier (copayment) pharmacy benefit structures on medication utilization behavior...
- Categorization of infliximab dose changes and healthcare utilization and expenditures for patients with rheumatoid arthritis in commercially insured and Medicare-eligible populationsKavita V Nair
University of Colorado Denver, Aurora, CO, USA
Curr Med Res Opin 25:303-14. 2009..To evaluate how changes in infliximab dose influence resource utilization and expenditures for patients with rheumatoid arthritis (RA)...
- Comparison of patient characteristics and gout-related health-care resource utilization and costs in patients with frequent versus infrequent gouty arthritis attacksJoseph J Saseen
University of Colorado Anschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences, Mail Stop C238, 12850 E Montview Blvd, V20 2126, Aurora, CO 80045, USA
Rheumatology (Oxford) 51:2004-12. 2012..03). Conclusion. Patients with frequent gouty arthritis are likely to have absolute and/or relative contraindications to gout medications and higher gout-related treatment costs...
- Persistent use of against-label statin-fibrate combinations from 2003-2009 despite United States Food and Drug Administration dose restrictionsJulie C Alford
Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Anschutz Medical Campus, Aurora, CO 80045, USA
Pharmacotherapy 32:623-30. 2012..To describe the prevalence of prescribing against-label statin-fibrate combination therapy...
- An evaluation of the impact of patient cost sharing for antihypertensive medications on adherence, medication and health care utilization, and expendituresJacqueline A Pesa
Janssen Scientific Affairs, LLC, Louisville, CO, USA
Patient Prefer Adherence 6:63-72. 2012....
- Costs and outcomes associated with clopidogrel discontinuation in Medicare beneficiaries with acute coronary syndrome in the coverage gapRobert Lee Page
School of Pharmacy, Department of Clinical Pharmacy, University of Colorado Anschutz Medical Campus, Aurora, CO
Drug Healthc Patient Saf 4:67-74. 2012..No data exist regarding the effect of the Medicare Part D coverage gap on medical costs and outcomes in Medicare beneficiaries who discontinue their clopidogrel upon entering the coverage gap...
- Understanding barriers to medication adherence in the hypertensive population by evaluating responses to a telephone surveyKavita V Nair
School of Pharmacy, University of Colorado, Aurora, CO, USA
Patient Prefer Adherence 5:195-206. 2011..Using customized telephonic outreach, we examined specific patient-reported barriers influencing hypertensive patients' nonadherence to medication in order to identify targeted interventions...
- The economic burden of acute coronary syndromes for employees and their dependents: medical and productivity costsRobert L Page
Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA
J Occup Environ Med 55:761-7. 2013..To determine the total burden of illness, including direct and indirect costs for employees and their dependents with acute coronary syndrome (ACS)...
- Patient-level medication regimen complexity across populations with chronic diseaseAnne M Libby
Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA
Clin Ther 35:385-398.e1. 2013..A gap exists in the study of a patient-level medication regimen complexity metric across disease-specific populations...
- Description of antihypertensive use in patients with resistant hypertension prescribed four or more agentsMichele R Hanselin
Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, 12850 E Montview Blvd, V20 2126, Aurora, CO 80045, USA
Hypertension 58:1008-13. 2011..Moreover, minimally efficacious combinations, such as an angiotensin-converting enzyme inhibitor with an angiotensin receptor blocker, were prescribed at higher rates than evidence-based and recommended agents...
- Quality assessment of dyslipidemia in managed care: current best evidence should be used to benchmark qualityKavita V Nair
School of Pharmacy, University of Colorado at Denver and Health Sciences Center, Denver, CO 80262 0001, USA
Ann Pharmacother 40:124-7. 2006..We propose a broad framework that provides health plans with guidance on developing a new quality measure for dyslipidemia that focuses on pharmacotherapy...
- Consumer responses to a pharmacy benefit report cardKavita V Nair
School of Pharmacy, University of Colorado Health Sciences Center, USA
J Health Care Finance 31:55-72. 2004..The pharmacy benefit report card could be an useful tool for specific populations such as those with an increased need for medication...
- Pharmacoeconomics and outcomes research degree-granting PhD programs in the United StatesJulia F Slejko
Department of Clinical Pharmacy, Center for Pharmaceutical Outcomes Research, University of Colorado Aschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO 80045, USA
Res Social Adm Pharm 9:108-13. 2013..Evidence is missing on showcasing current practices of degree programs specific to the field of pharmaceutical outcomes research...
- Do consumers' attitudes predict prescription purchasing behavior?Kavita V Nair
School of Pharmacy, University of Colorado Health Sciences Center, Denver, USA
Manag Care Interface 16:22-7, 55. 2003..The findings appear to support the concept of three-tier plans, and increasing copayments seems to facilitate greater adherence to health plan formularies...
- Utilization characteristics of spinal interventionsZach I Abbott
Department of Physical Medicine and Rehabilitation, University of Colorado School of Medicine, 12631 East 17th Ave, Room 2507, Mail Stop F493, Aurora, CO 80045, USA
Spine J 12:35-43. 2012..Although Medicare utilization has been well characterized, the utilization patterns for privately insured individuals are not clearly known...